Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013

被引:16
作者
Brooks, Jessica M. [1 ]
Petersen, Curtis [2 ,3 ]
Kelly, Stephanie M. [3 ]
Reid, Manney C. [4 ]
机构
[1] James J Peters VA Med Ctr, Geriatr Res Educ & Clin Ctr, 130 West Kingsbridge Rd, Bronx, NY 10468 USA
[2] Dartmouth Coll, Geisel Sch Med, Quantiat Biomed Sci, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[3] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY USA
关键词
depression; epidemiology; older adults; opioids; prescriptions; PRESCRIPTION OPIOIDS; SUBSTANCE-ABUSE; NONCANCER PAIN; INCREASED RISK; ASSOCIATION; THERAPY; ANALGESICS; DISORDERS; DEATHS; TRENDS;
D O I
10.1002/gps.5157
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives To investigate the relationships between depressive symptoms and opioid potency among adults aged 50 years and older reporting use of one or more prescription opioids in the past 30 days. Materials/Design Adjusted multiple linear regression models were conducted with 2005-2013 files from a secondary cross-sectional dataset, the National Health and Nutrition Examination Survey (NHANES). Respondents were community-dwelling, noninstitutionalized adults 50 years or older (n = 1036). Predictor variables included a positive screen for minor depression symptoms (Patient Health Questionnaire [PHQ-9] score greater than or equal to 5 and less than or equal to 9), moderate depression symptoms (PHQ-9 greater than or equal to 10 and less than or equal to 14), and severe depression symptoms (PHQ-9 greater than or equal to 15). Criterion variables included weaker-than-morphine analgesics (eg, codeine and tramadol) and morphine-equivalent opioids (eg, morphine and hydrocodone), which served as the reference category, as well as stronger-than-morphine opioid analgesics (eg, fentanyl and oxycodone). Results Prevalence rates for symptoms of minor depression, moderate depression, and severe depression were n = 236 (22.8%), n = 135 (13.0%), and n = 122 (11.8%), respectively. Severe depression was significantly associated with high-potency opioid use (odds ratio [OR]: 2.27; confidence interval [CI], 1.16-4.46). In post hoc tests, severe depression remained significantly associated with high-potency opioid use only among respondents without arthritis (OR: 5.80; CI, 1.59-21.13). Conclusions Compared with older adults without depressive symptoms, older adults with severe depressive symptoms are more likely to be taking high-potency opioid medications. Future prescription opioid medication research should prioritize investigations among older adults with pain-related diagnoses, other than arthritis, reporting preexisting or new symptoms of severe depression.
引用
收藏
页码:1481 / 1489
页数:9
相关论文
共 40 条
[1]  
American Academy of PAIN Medicine, 2013, US OP TREATM CHRON P
[2]  
[Anonymous], 2015, PRESCRIPTION OPIOID
[3]  
[Anonymous], 2017, NATL HLTH NUTR EXAMI
[4]   A Detailed Exploration Into the Association of Prescribed Opioid Dosage and Overdose Deaths Among Patients With Chronic Pain [J].
Bohnert, Amy S. B. ;
Logan, Joseph E. ;
Ganoczy, Dara ;
Dowell, Deborah .
MEDICAL CARE, 2016, 54 (05) :435-441
[5]   Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths [J].
Bohnert, Amy S. B. ;
Valenstein, Marcia ;
Bair, Matthew J. ;
Ganoczy, Dara ;
McCarthy, John F. ;
Ilgen, Mark A. ;
Blow, Frederic C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (13) :1315-1321
[6]   Trends in long-term opioid therapy for chronic non-cancer pain [J].
Boudreau, Denise ;
Von Korff, Michael ;
Rutter, Carolyn M. ;
Saunders, Kathleen ;
Ray, G. Thomas ;
Sullivan, Mark D. ;
Campbell, Cynthia I. ;
Merrill, Joseph O. ;
Silverberg, Michael J. ;
Banta-Green, Caleb ;
Weisner, Constance .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (12) :1166-1175
[7]   Trends in long-term opioid therapy for noncancer pain among persons with a history of depression [J].
Braden, Jennifer Brennan ;
Sullivan, Mark D. ;
Ray, G. Thomas ;
Saunders, Kathleen ;
Merrill, Joseph ;
Silverberg, Michael J. ;
Rutter, Carolyn M. ;
Weisner, Constance ;
Banta-Green, Caleb ;
Campbell, Cynthia ;
Von Korff, Michael .
GENERAL HOSPITAL PSYCHIATRY, 2009, 31 (06) :564-570
[8]   Prevalence rates of arthritis among US older adults with varying degrees of depression: Findings from the 2011 to 2014 National Health and Nutrition Examination Survey [J].
Brooks, Jessica M. ;
Titus, Alexander J. ;
Polenick, Courtney A. ;
Orzechowski, Nicole M. ;
Reid, Manney Carrington ;
MacKenzie, Todd A. ;
Bartels, Stephen J. ;
Batsis, John A. .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (12) :1671-1679
[9]   Designer drugs: a medicinal chemistry perspective [J].
Carroll, F. Ivy ;
Lewin, Anita H. ;
Mascarella, S. Wayne ;
Seltzman, Herbert H. ;
Reddy, P. Anantha .
ADDICTION REVIEWS, 2012, 1248 :18-38
[10]   Which medications to avoid in people at risk of delirium: a systematic review [J].
Clegg, Andrew ;
Young, John B. .
AGE AND AGEING, 2011, 40 (01) :23-29